vs

Side-by-side financial comparison of DIVERSIFIED HEALTHCARE TRUST (DHC) and Genius Sports Ltd (GENI). Click either name above to swap in a different company.

Genius Sports Ltd is the larger business by last-quarter revenue ($510.9M vs $379.6M, roughly 1.3× DIVERSIFIED HEALTHCARE TRUST). DIVERSIFIED HEALTHCARE TRUST runs the higher net margin — -5.6% vs -12.3%, a 6.7% gap on every dollar of revenue. Genius Sports Ltd produced more free cash flow last quarter ($69.6M vs $-166.4M). Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 1.2%).

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

DHC vs GENI — Head-to-Head

Bigger by revenue
GENI
GENI
1.3× larger
GENI
$510.9M
$379.6M
DHC
Higher net margin
DHC
DHC
6.7% more per $
DHC
-5.6%
-12.3%
GENI
More free cash flow
GENI
GENI
$236.0M more FCF
GENI
$69.6M
$-166.4M
DHC
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
1.2%
DHC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DHC
DHC
GENI
GENI
Revenue
$379.6M
$510.9M
Net Profit
$-21.2M
$-63.0M
Gross Margin
25.2%
Operating Margin
-12.6%
-11.5%
Net Margin
-5.6%
-12.3%
Revenue YoY
-0.0%
Net Profit YoY
75.7%
EPS (diluted)
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DHC
DHC
GENI
GENI
Q4 25
$379.6M
$510.9M
Q3 25
$388.7M
$335.4M
Q2 25
$382.7M
$215.2M
Q1 25
$386.9M
$119.7M
Q4 24
$379.6M
$413.0M
Q3 24
$373.6M
$285.8M
Q2 24
$371.4M
$184.1M
Q1 24
$370.8M
$97.2M
Net Profit
DHC
DHC
GENI
GENI
Q4 25
$-21.2M
$-63.0M
Q3 25
$-164.0M
Q2 25
$-91.6M
$-47.3M
Q1 25
$-9.0M
$-25.5M
Q4 24
$-87.4M
$-85.5M
Q3 24
$-98.7M
$-47.1M
Q2 24
$-97.9M
$-35.5M
Q1 24
$-86.3M
$-25.2M
Gross Margin
DHC
DHC
GENI
GENI
Q4 25
25.2%
Q3 25
24.2%
Q2 25
19.1%
Q1 25
10.7%
Q4 24
16.7%
Q3 24
20.5%
Q2 24
18.6%
Q1 24
9.8%
Operating Margin
DHC
DHC
GENI
GENI
Q4 25
-12.6%
-11.5%
Q3 25
-43.4%
-15.3%
Q2 25
-24.5%
-21.0%
Q1 25
-2.7%
-20.3%
Q4 24
-26.1%
-18.0%
Q3 24
-26.5%
-13.9%
Q2 24
-23.0%
-16.8%
Q1 24
-23.7%
-23.7%
Net Margin
DHC
DHC
GENI
GENI
Q4 25
-5.6%
-12.3%
Q3 25
-42.2%
Q2 25
-23.9%
-22.0%
Q1 25
-2.3%
-21.3%
Q4 24
-23.0%
-20.7%
Q3 24
-26.4%
-16.5%
Q2 24
-26.3%
-19.3%
Q1 24
-23.3%
-25.9%
EPS (diluted)
DHC
DHC
GENI
GENI
Q4 25
$-0.09
Q3 25
$-0.68
Q2 25
$-0.38
Q1 25
$-0.04
Q4 24
$-0.37
Q3 24
$-0.41
Q2 24
$-0.41
Q1 24
$-0.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DHC
DHC
GENI
GENI
Cash + ST InvestmentsLiquidity on hand
$105.4M
$280.6M
Total DebtLower is stronger
$2.4B
Stockholders' EquityBook value
$1.7B
$724.5M
Total Assets
$4.4B
$1.1B
Debt / EquityLower = less leverage
1.47×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DHC
DHC
GENI
GENI
Q4 25
$105.4M
$280.6M
Q3 25
$201.4M
$110.2M
Q2 25
$141.8M
$110.2M
Q1 25
$302.6M
$110.2M
Q4 24
$144.6M
$100.3M
Q3 24
$256.5M
$100.3M
Q2 24
$265.6M
$100.3M
Q1 24
$207.1M
$100.3M
Total Debt
DHC
DHC
GENI
GENI
Q4 25
$2.4B
Q3 25
Q2 25
Q1 25
Q4 24
$3.1B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
DHC
DHC
GENI
GENI
Q4 25
$1.7B
$724.5M
Q3 25
$1.7B
$572.4M
Q2 25
$1.9B
$572.4M
Q1 25
$1.9B
$572.4M
Q4 24
$2.0B
$573.0M
Q3 24
$2.0B
$573.0M
Q2 24
$2.1B
$573.0M
Q1 24
$2.2B
$573.0M
Total Assets
DHC
DHC
GENI
GENI
Q4 25
$4.4B
$1.1B
Q3 25
$4.7B
$792.3M
Q2 25
$4.8B
$792.3M
Q1 25
$5.0B
$792.3M
Q4 24
$5.1B
$775.7M
Q3 24
$5.3B
$775.7M
Q2 24
$5.3B
$775.7M
Q1 24
$5.3B
$775.7M
Debt / Equity
DHC
DHC
GENI
GENI
Q4 25
1.47×
Q3 25
Q2 25
Q1 25
Q4 24
1.56×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DHC
DHC
GENI
GENI
Operating Cash FlowLast quarter
$-19.6M
$81.9M
Free Cash FlowOCF − Capex
$-166.4M
$69.6M
FCF MarginFCF / Revenue
-43.8%
13.6%
Capex IntensityCapex / Revenue
38.7%
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-280.3M
$33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DHC
DHC
GENI
GENI
Q4 25
$-19.6M
$81.9M
Q3 25
$-49.3M
$-4.8M
Q2 25
$53.0M
$-1.2M
Q1 25
$-3.2M
$-14.6M
Q4 24
$112.2M
$14.9M
Q3 24
$21.1M
$-9.2M
Q2 24
$44.3M
Q1 24
$28.6M
Free Cash Flow
DHC
DHC
GENI
GENI
Q4 25
$-166.4M
$69.6M
Q3 25
$-89.8M
$-14.2M
Q2 25
$18.8M
$-5.8M
Q1 25
$-42.9M
$-16.0M
Q4 24
$-89.5M
$11.3M
Q3 24
$-26.1M
$-11.6M
Q2 24
$3.3M
Q1 24
$-18.1M
FCF Margin
DHC
DHC
GENI
GENI
Q4 25
-43.8%
13.6%
Q3 25
-23.1%
-4.2%
Q2 25
4.9%
-2.7%
Q1 25
-11.1%
-13.4%
Q4 24
-23.6%
2.7%
Q3 24
-7.0%
-4.1%
Q2 24
0.9%
Q1 24
-4.9%
Capex Intensity
DHC
DHC
GENI
GENI
Q4 25
38.7%
2.4%
Q3 25
10.4%
2.8%
Q2 25
8.9%
2.1%
Q1 25
10.2%
1.2%
Q4 24
53.1%
0.9%
Q3 24
12.6%
0.9%
Q2 24
11.0%
Q1 24
12.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DHC
DHC

Senior Housing Operating Portfolio Segment$323.4M85%
Rental Income$56.2M15%

GENI
GENI

Segment breakdown not available.

Related Comparisons